@krispi
Thank you for your excellent post.
I agree with the medical aspects.
I disagree with the 1 in 250 chance valuation calculation. That would be correct if no more expenditure was required to reach drug approval stage. But there's a lot more expenditure required to reach drug approval stage. The market is taking that into account, although maybe inaccurately.
- Forums
- ASX - By Stock
- ACW
- XanaHES and its implications for Actinogen
XanaHES and its implications for Actinogen, page-3
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
0.002(2.56%) |
Mkt cap ! $215.9M |
Open | High | Low | Value | Volume |
7.8¢ | 8.5¢ | 7.6¢ | $641.9K | 7.864M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 302521 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.1¢ | 44444 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 202521 | 0.080 |
2 | 410594 | 0.079 |
2 | 80486 | 0.078 |
2 | 138369 | 0.077 |
4 | 212901 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.081 | 44444 | 1 |
0.082 | 100000 | 1 |
0.083 | 67600 | 1 |
0.084 | 286483 | 2 |
0.085 | 267991 | 3 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online